EVD tips and tricks
Neuro Resus
Catherine Bell takes us through how to troubleshoot problems commonly encountered when looking after patients who have an external ventricular drain (EVD) in situ. Issues with using brain tissue oxygen monitors are also discussed. A highly practical session aimed at bedside clinicians. This presentation was delivered by Catherine Bell at . Want more content about EVD? Visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
aSAH: Dilating the Dogma of Vasospasm
Neuro Resus
Angiographic vasospasm and more accurately, delayed cerebral ischemia, continue to contribute to morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). It is known that angiographic vasospasm is common after SAH, occurring in two-thirds of patients. This presentation was delivered by Rob Loch MacDonald at . Want more content about aSAH? Visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
Subarachnoid Haemorrhage: a patient and family experience
Neuro Resus
Lizzy suffered a substantial aneurysmal subarachnoid haemorrhage that left her critically unwell, requiring a long stay in intensive care recovering from the consequences and complications of this devastating form of stroke. Now a couple of years after her haemorrhage, Lizzy has come so far. She and her husband Gordon describe their experiences, right from the day it all began and through those tumultuous first few weeks, to where she is today. This open and honest account gives us all invaluable insight into what it’s like to go through the subarachnoid haemorrhage journey from a patient...
info_outline
Brain Tissue Oxygen Monitoring - The Bonanza Trial (It’s Not What You’ve Got It’s What You Do With It)
Neuro Resus
Andrew Udy talks about the ongoing which is assessing whether an algorithm that incorporates both ICP and brain tissue oxygen (PbTO2) can improve outcomes after traumatic brain injury (TBI). Like with all monitoring, how the PbTO2 is interpreted and managed is critical and the devil is in the detail! This presentation was delivered by Andrew Udy at . Want more content about The Bonanza Trial? Visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
Ketamine for Brain Injury
Neuro Resus
Historically, when it came to brain injury, ketamine had a bad rap. Much of that dogma was dispelled in the last 20 years, and ketamine is now frequently used as an induction agent in acute brain injury, especially traumatic brain injury, partially due to the favorable effects on haemodynamics. However a new application of ketamine is now being explored - whether ketamine may be able to reduce secondary brain injury. In this talk Toby Jeffcote initially takes us through all the sedatives currently used in brain injury and the evidence to support their use. He then covers the history of...
info_outline
Cortical Spreading Depolarisation in Neurological Disease - An Introduction
Neuro Resus
Cortical spreading depolarization (CSD) is a spreading loss of ion homeostasis, altered vascular response, change in synaptic architecture, and subsequent depression in electrical activity following an inciting neurological injury. This presentation was delivered by Toby Jeffcote at . Want more content about CSD? Visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
There is no such thing as mild, moderate and severe TBI
Neuro Resus
Andrew Chow vs Andrew Udy This debate was set up to discuss the issues with categorising traumatic brain injury (TBI). The current system using GCS to divide patients into mild, moderate and severe has been criticised in recent times, with calls for a more nuanced approach. The debate was a just bit of fun but does highlight the key issues. Chowie didn’t get to choose which side to argue for :) Andrew Chow, Intensivist with a neurosurgical background, argues that the current categorisation system for TBI works, and makes sense! He tackles us through the history of this system, and why...
info_outline
TBI: when to stop and when to give time
Neuro Resus
Dr Nick Little is an experienced Neurosurgeon who's looked after patients with traumatic brain injury for his whole career. Here he discusses the difficulties of prognostication following traumatic brain injury (TBI). This podcast was recorded at the Brain Symposium which took place in March 2023. For more talks and content like this, visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
EEG and Status Epilepticus
Neuro Resus
Tania Farrar is a neurologist and epileptologist with expertise in continuous EEG (cEEG) and status epilepticus (SE). This talk covers what a seizure is, what status is, including focal and generalised status epilepticus. This podcast was recorded at the Brain Symposium which took place in March 2023. For more talks and content like this, visit or to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, .
info_outline
Neuro Rehab: What Does Severe Disability Mean?
Neuro Resus
Stuart Browne is a Neuro Rehab specialist from Sydney. He discusses what "severe disability" really means. Severe disability is more common than many realise - about 6% of the Australian population. Stuart discusses how health is more than simply physical recovery and how it is a multidimensional construct. He covers how permanent disability doesn't necessarily equate to a poor quality of life. He also discusses the long timespan of recovery, which is often much longer than appreciated. He specifically discusses "Locked-in Syndrome" and how the survivors have surprisingly positive...
info_outlineHistorically, when it came to brain injury, ketamine had a bad rap. Much of that dogma was dispelled in the last 20 years, and ketamine is now frequently used as an induction agent in acute brain injury, especially traumatic brain injury, partially due to the favorable effects on haemodynamics.
However a new application of ketamine is now being explored - whether ketamine may be able to reduce secondary brain injury.
In this talk Toby Jeffcote initially takes us through all the sedatives currently used in brain injury and the evidence to support their use. He then covers the history of ketamine use and the background to new research in use as a therapeutic agent.
This podcast was recorded at the Brain Symposium which took place in March 2023. For more talks and content like this, visit neuroresus.com or subscribe to be notified of new podcast releases via email.
To express your interest in attending the 2024 Neuroresus live course, click here.